Overview

Perceptronix Medical Inc. is a privately owned, cancer diagnostics company based in Vancouver, Canada. The company was founded in 1999 to commercialize innovative cancer diagnosis technologies developed in partnership with the BC Cancer Agency, a renowned cancer research and treatment facility with a successful track record in implementing early cancer detection programs.

We believe early diagnosis is the key to improving outcomes for cancer patients. Perceptronix's mission is to commercialize effective, clinically-relevant technologies for the earlier diagnosis of cancer. The company’s initial focus is on a complementary portfolio of diagnostic products to improve lung cancer outcomes. Perceptronix has developed proprietary and novel methods that link into the diagnostic chain: detection, localization, diagnosis, treatment, and follow-up.

(1) Licensed for sale in Canada & EU; (2) Licensed for sale in Canada, EU & USA; (3) In development, license not yet issued.

Perceptronix holds an ISO 13485 quality certificate and is ISO 9001:2000 certified.